Foundation Medicine Inc.

NASDAQ: FMI · Real-Time Price · USD
137.00
0.00 (0.00%)
At close: Jun 29, 2019, 12:07 AM

Foundation Medicine Revenue Breakdown

Period Ending Dec 31, 2017
Molecular Information Services Revenue 91.69M
Molecular Information Services Revenue Growth n/a
Pharma Research And Development Services Revenue 10.92M
Pharma Research And Development Services Revenue Growth n/a

Operating Expense Breakdown

Period Ending Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 36.91M 38.17M 37.03M 33.56M 34.76M 31.71M 28.89M 27.67M 26.98M 23.02M 21.2M 23.47M 36.31M 18.66M
Selling, General, and Administrative Revenue Growth -3.31% +3.08% +10.36% -3.47% +9.62% +9.75% +4.44% +2.53% +17.24% +8.55% -9.64% -35.37% +94.56% n/a
Research and Development Revenue 24.7M 23.86M 22.85M 22.4M 22.97M 23.29M 18.18M 17.24M 18.5M 13.46M 12.77M 12.17M 10.26M 8.69M
Research and Development Revenue Growth +3.53% +4.41% +2.02% -2.50% -1.34% +28.10% +5.45% -6.82% +37.49% +5.41% +4.85% +18.70% +18.05% n/a
Sales and Marketing Revenue 17.14M 17.48M 16.62M 16.56M 17.11M 16.44M 15.02M 14.65M 14.48M 13.79M 12.4M 14.27M 12.54M 9.82M
Sales and Marketing Revenue Growth -1.94% +5.17% +0.39% -3.27% +4.13% +9.41% +2.52% +1.19% +4.99% +11.23% -13.09% +13.75% +27.71% n/a